AI-generated from publicly available materials.AI technologies are being developed to enhance early detection of dementia, aiming to improve patient outcomes and care opportunities.
Vebjørn Andersson, a PhD student and dementia researcher, highlights the prolonged diagnostic process for dementia, which often results in patients missing critical early intervention opportunities. With dementia impacting around 57 million individuals globally, many diagnoses occur only after significant brain changes have taken place. The AI-Mind project, funded by the EU, seeks to address this gap by creating AI tools that identify individuals at risk of dementia before clinical symptoms manifest.
The AI-Mind team has invested over 50,000 hours analyzing data from 1,000 individuals to develop two diagnostic tools. The AI-Mind Connector focuses on detecting patterns in brain electrical activity associated with mild cognitive impairment (MCI), while the AI-Mind Predictor assesses various risk factors, including cognitive function and lifestyle elements, to forecast the likelihood of progression to dementia within a two to five-year timeframe. This comprehensive approach aims to facilitate earlier interventions that could potentially delay or prevent dementia onset.
While there is no cure for dementia, certain modifiable lifestyle factors can be addressed to mitigate risks. The tools also serve a dual purpose: they provide clarity to individuals experiencing cognitive changes and assist families in planning for the future. As the project moves toward clinical application, researchers are collaborating with industry partners and seeking funding to expand their work, with the hope that these AI solutions can improve dementia care, particularly in resource-limited settings.
This innovative approach underscores the importance of integrating AI into healthcare, not as a replacement for human judgment, but as a supportive tool for informed decision-making in patient care.